Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts

Equality Impact Assessment (Guidance development) (PDF 174 KB)

Final appraisal determination

Final appraisal determination document (PDF 378 KB)

Committee papers (PDF 575 KB)

Committee papers committee presentation (PDF 681 KB)

Draft guidance

Appraisal consultation document (PDF 390 KB)

Committee papers (PDF 7.05 MB)

Final scope (PDF 104 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 247 KB)

Equality impact assessment (Scoping) (PDF 123 KB)

Final matrix (MSWord 77 KB)

Draft scope (pre-referral) (PDF 111 KB)

Provisional matrix (pre-referral) (PDF 102 KB)